Bioprinting High‐Cell‐Density Cardiac Tissue Constructs With Sustained Contractile Function
Advanced Healthcare Materials · 2026-08 · 15 (31)
DOI: 10.1002/adhm.71446 ↗At a glance
Journal article in Advanced Healthcare Materials, published online on 2026-07-19. Written by Priscila Melo and 8 co-authors. Institution: School of Engineering, Newcastle University, Newcastle Upon Tyne, UK. Major MEDLINE topics: Myocytes, Cardiac, Bioprinting, Tissue Engineering, Tissue Scaffolds. 71 references. The full text is freely available (open access, CC BY 4.0). Funded by: UK EPSRC, European Union's Horizon Europe research and innovation program, National Centre for the Replacement, Refinement and Reduction of Animals in Research.
Abstract (original language)
The development of in vitro models that reflect key elements of cardiac physiology remains a major challenge for assessing cardiotoxicity and drug efficacy. Tissue engineering approaches, together with advanced biofabrication technologies, provide a new way to recreate the target tissue composition and organization, enabling the development of 3D in vitro models able to mimic the biological function of the target tissue. Here, we present a novel 3D bioprinted cardiac in vitro model fabricated using reactive jet impingement (ReJI), an advanced biofabrication technique that enables rapid, high‐resolution deposition of living cells within a bespoke hydrogel matrix composed of type I collagen, alginate, and fibrin. Using the murine HL‐1 cardiomyocyte cell line, we demonstrate for the first time that ReJI bioprinting supports the formation of stable, functional 3D cardiac constructs exhibiting spontaneous and sustained contractility over 21 days, without external stimulation. The 3D models expressed key biomarkers related to cell contraction: desmin, myosin, and gap junction alpha‐1 (GJA1). In particular, cultures showed increased early‐stage expression of GJA1, indicative of the formation of gap junction structures within the 3D culture, and were susceptible to drug‐induced dysrhythmia, confirming their significant potential for use in cardiotoxicity testing.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Engineering, Newcastle University, Newcastle Upon Tyne, UK.
- Bio-Imaging Unit, Medical School, Newcastle University, Newcastle Upon Tyne, UK.
- School of Pharmacy and Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.
ORCID profiles: Ana Marina Ferreira, Jason Gill
Funding
- UK EPSRC
- European Union's Horizon Europe research and innovation program
- National Centre for the Replacement, Refinement and Reduction of Animals in Research
Cite
APA
Melo, P., Tung, W. T., Lewis, H., Hettiarachchilage, K., Tzivelekis, B., Berlinguer-Palmini, R., Ferreira, A. M., Gill, J., & Dalgarno, K. (2026). Bioprinting High‐Cell‐Density Cardiac Tissue Constructs With Sustained Contractile Function. Advanced Healthcare Materials, 15(31). https://doi.org/10.1002/adhm.71446
Vancouver
Melo P, Tung WT, Lewis H, Hettiarachchilage K, Tzivelekis B, Berlinguer-Palmini R, et al. Bioprinting High‐Cell‐Density Cardiac Tissue Constructs With Sustained Contractile Function. Advanced Healthcare Materials. 2026;15(31). doi:10.1002/adhm.71446
BibTeX
@article{Melo2026,
author = {Melo, Priscila and Tung, Wing Tai and Lewis, Harvey and Hettiarachchilage, Kavin and Tzivelekis, Babis and Berlinguer-Palmini, Rolando and Ferreira, Ana Marina and Gill, Jason and Dalgarno, Kenneth},
title = {Bioprinting High‐Cell‐Density Cardiac Tissue Constructs With Sustained Contractile Function},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {31},
doi = {10.1002/adhm.71446}
}
EUVIMED